Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription Articles published in Ann Surg Retrieve available abstracts of 42 articles: HTML format

Single Articles

November 2026
1. GIORGI L, Guidozzi N, Salem R, Chou WK, et al
   The Impact of Anastomotic Leak After Esophagectomy on Long-term Survival in the Modern Era of Management (ALES Study): A Multicenter Cohort Study.
   Ann Surg. 2026;284:978-984.
   PubMed     Abstract available
   
   
   
2. BADALONI F, Zeyara A, Kuiper GM, Vanstraelen S, et al
   Intraoperative Adverse Events in Robot-Assisted Minimally Invasive Esophagectomy (RAMIE): Incidence, Management, and Impact on Surgical Outcomes.
   Ann Surg. 2026;284:957-963.
   PubMed     Abstract available
   
   
   October 2026
3. KRAUSS DT, van der Sluis PSL, Schiffmann LM, Schlosser HA, et al
   The Impact of Robotics on Benchmarking Criteria for the Surgical Treatment of Esophageal Cancer in Western Centers- An Evaluation Using the IDEAL Framework.
   Ann Surg. 2026 Oct 1. doi: 10.1097/SLA.0000000000007230.
   PubMed     Abstract available
   
   
   August 2026
4. GANGARAM PANDAY SSG, Oudijk L, Lagarde SM, Mostert B, et al
   Local Regrowth After Neoadjuvant Chemoradiotherapy and Active Surveillance for Esophageal Cancer: An Analysis of Surgical Specimens From the SANO Trial.
   Ann Surg. 2026 Aug 21. doi: 10.1097/SLA.0000000000007179.
   PubMed     Abstract available
   
   
   
5. SARICI IS, Eriksson SE, Chaudhry N, Zheng P, et al
   Socioeconomic Disparities in the Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus to Esophageal Adenocarcinoma.
   Ann Surg. 2026;284:305-313.
   PubMed     Abstract available
   
   
   July 2026
6. GUIDOZZI N, Chou WK, Giorgi L, Salem R, et al
   The Prognostic Impact of Lymph Node Yield Upon Survival in Esophageal Cancer Broken Down by Neoadjuvant Strategy: A Multicenter European Cohort Study.
   Ann Surg. 2026 Jul 31. doi: 10.1097/SLA.0000000000007164.
   PubMed     Abstract available
   
   
   May 2026
7. GANGARAM PANDAY SSG, In 't Veld D, Mostert B, Doukas M, et al
   Pathological Outcomes After Uncertain Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.
   Ann Surg. 2026 May 25. doi: 10.1097/SLA.0000000000007101.
   PubMed     Abstract available
   
   
   April 2026
8. LUKETICH JD, Sarkaria ID, Levy RM, Alicuben ET, et al
   A Phase III Randomized Controlled Trial of Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Minimally Invasive Esophagectomy or Robot-assisted Minimally Invasive Esophagectomy.
   Ann Surg. 2026;283:569-580.
   PubMed     Abstract available
   
   
   March 2026
9. BOOKA E, Kato K, Ito Y, Daiko H, et al
   Prognostic Impact of Postoperative Complications After Neoadjuvant Therapy Followed by Esophagectomy for Esophageal Cancer: An Exploratory Analysis of Phase III Trial JCOG1109.
   Ann Surg. 2026 Mar 6. doi: 10.1097/SLA.0000000000007045.
   PubMed     Abstract available
   
   
   February 2026
10. O'NEILL LM, Guinan E, Doyle SL, Bennett AE, et al
    The RESTORE Randomized Controlled Trial: Impact of a Multidisciplinary Rehabilitative Program on Cardiorespiratory Fitness in Esophagogastric Cancer Survivorship: Erratum.
    Ann Surg. 2026;283:e5-e6.
    PubMed    
    
    
    November 2025
11. RAFTERY NB, Elliott JA, Muldoon C, Ryan C, et al
    Tackling Prevention and Early Diagnosis of Esophageal Adenocarcinoma Through a National Barrett's Registry and Scientific Network.
    Ann Surg. 2025;282:742-749.
    PubMed     Abstract available
    
    
    
12. SMYTH E, O'Neill LM, Kearney N, Sheill G, et al
    Preoperative Exercise to Improve Fitness in Patients Undergoing Complex Surgery for Cancer of the Lung or Esophagus (PRE-HIIT): A Randomized Controlled Trial.
    Ann Surg. 2025;282:690-698.
    PubMed     Abstract available
    
    
    September 2025
13. WANG J, Wu Z, Verhoeven RHA, Goense L, et al
    A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy: A Study Based on the Netherlands Cancer Registry.
    Ann Surg. 2025 Sep 23. doi: 10.1097/SLA.0000000000006869.
    PubMed     Abstract available
    
    
    August 2025
14. OKUI J, Matsuda S, Nagashima K, Sato Y, et al
    Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.
    Ann Surg. 2025 Aug 25. doi: 10.1097/SLA.0000000000006919.
    PubMed     Abstract available
    
    
    
15. ANTUNEZ AG, Sinco BR, Saucke MC, Bushaw KJ, et al
    Making Choices: A Multi-institutional, Longitudinal Cohort Study Assessing Changes in Treatment Outcome Valuation for Low-risk Thyroid Cancer.
    Ann Surg. 2025;282:275-282.
    PubMed     Abstract available
    
    
    July 2025
16. FEENSTRA ML, Kooij CD, Eshuis WJ, de Groot EM, et al
    Paravertebral Versus EPidural Analgesia in Minimally Invasive Esophageal ResectioN (PEPMEN): A Randomized Controlled Multicenter Trial.
    Ann Surg. 2025;282:29-36.
    PubMed     Abstract available
    
    
    June 2025
17. NAKAUCHI M, Walch HS, Nussenzweig S, Carr R, et al
    Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on From the Siewert Classification.
    Ann Surg. 2025;281:989-996.
    PubMed     Abstract available
    
    
    March 2025
18. TAKEI S, Kotani D, Laliotis G, Sato K, et al
    Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.
    Ann Surg. 2025 Mar 21. doi: 10.1097/SLA.0000000000006699.
    PubMed     Abstract available
    
    
    
19. NA KJ, Kang CH, Kim YR, Kang MJ, et al
    Comparison of Clinical Outcomes and Postoperative Nutritional Status Between Early and Late Oral Feeding After Esophagectomy: An Open Labeled Randomized Controlled Trial.
    Ann Surg. 2025;281:388-394.
    PubMed     Abstract available
    
    
    November 2024
20. SIHAG S
    Real-world Application of Endoscopic Resection for Early-stage Esophageal Cancer: do we need to rethink the guidelines?
    Ann Surg. 2024 Nov 20. doi: 10.1097/SLA.0000000000006593.
    PubMed    
    
    
    
21. PUCCETTI F, Cinelli L, Barbieri LA, Socci D, et al
    The Near-Infrared Visualization and Preemptive Ligation of the Thoracic Duct Effectively Reduce the Chyle Leak Incidence After Minimally Invasive Esophagectomy.
    Ann Surg. 2024;280:780-787.
    PubMed     Abstract available
    
    
    
22. WIRSIK NM, Kooij CD, Dempster N, Crnovrsanin N, et al
    Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2024;280:799-807.
    PubMed     Abstract available
    
    
    October 2024
23. MARKAR SR, Sgromo B, Evans R, Griffiths EA, et al
    The Prognostic Impact of Minimally Invasive Esophagectomy on Survival After Esophagectomy Following a Delayed Interval After Chemoradiotherapy: A Secondary Analysis of the DICE Study.
    Ann Surg. 2024;280:650-658.
    PubMed     Abstract available
    
    
    September 2024
24. PUCHER PH, Rahman SA, Bhandari P, Blencowe N, et al
    Prevalence and Risk Factors for Malignant Nodal Involvement in Early esophago-gastric Adenocarcinoma: Results from the Multicenter Retrospective Congress Study (endosCopic resectiON, esophaGectomy or Gastrectomy For Early Esophagogastric Cancers).
    Ann Surg. 2024 Sep 2. doi: 10.1097/SLA.0000000000006496.
    PubMed     Abstract available
    
    
    August 2024
25. DONLON NE, Moran B, Davern M, Davey MG, et al
    Evidence for the Positive Impact of Centralization in Esophageal Cancer Surgery.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006487.
    PubMed     Abstract available
    
    
    
26. OVERTOOM HCG, Eyck BM, van der Wilk BJ, Noordman BJ, et al
    Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006488.
    PubMed     Abstract available
    
    
    
27. WANG J, de Jongh C, Wu Z, de Groot EM, et al
    Impact of Preoperative Time Intervals for Neoadjuvant Chemoradiotherapy on Short-term Postoperative Outcomes of Esophageal Cancer Surgery: A Population-Based Study Using the Dutch Upper Gastrointestinal Cancer Audit (DUCA) Data.
    Ann Surg. 2024 Aug 8. doi: 10.1097/SLA.0000000000006476.
    PubMed     Abstract available
    
    
    July 2024
28. DEBOEVER N, Correa AM, Feldman H, Eisenberg M, et al
    Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival.
    Ann Surg. 2024;280:91-97.
    PubMed     Abstract available
    
    
    April 2024
29. HENCKENS SP, Schuring N, Elliott JA, Johar A, et al
    Recurrence and Survival after Minimally Invasive and Open Esophagectomy for Esophageal Cancer - A Post Hoc Analysis of the Ensure Study.
    Ann Surg. 2024 Apr 5. doi: 10.1097/SLA.0000000000006280.
    PubMed     Abstract available
    
    
    March 2024
30. AIOLFI A, Bona D, Bonitta G, Bonavina L, et al
    Short-term Outcomes of Different Techniques for Gastric Ischemic Preconditioning Before Esophagectomy: A Network Meta-analysis.
    Ann Surg. 2024;279:410-418.
    PubMed     Abstract available
    
    
    January 2024
31. PARK SY, Park B, Yun JK, Kim HR, et al
    Proposal of New ypStage Grouping System for Esophageal Squamous Cell Carcinoma Patients who Underwent Neoadjuvant Chemoradiotherapy followed by Surgery.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006204.
    PubMed     Abstract available
    
    
    December 2023
32. KARALIS JD, Ju MR, Yoon LY, Castro-Dubon EC, et al
    Serum Interleukin 6 Level is Associated With Overall Survival and Treatment Response in Gastric and Gastroesophageal Junction Cancer.
    Ann Surg. 2023;278:918-924.
    PubMed     Abstract available
    
    
    
33. OWEN RP, Chidambaram S, Griffiths EA, Sultan J, et al
    Multicenter, Prospective Cohort Study of Oesophageal Injuries and Related Clinical Outcomes (MUSOIC study).
    Ann Surg. 2023;278:910-917.
    PubMed     Abstract available
    
    
    November 2023
34. WIRSIK NM, Schmidt T, Nienhuser H, Donlon NE, et al
    Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2023;278:683-691.
    PubMed     Abstract available
    
    
    
35. VEZIANT J, Boudis F, Lenne X, Bruandet A, et al
    Outcomes Associated With Esophageal Perforation Management: Results From a French Nationwide Population-based Cohort Study.
    Ann Surg. 2023;278:709-716.
    PubMed     Abstract available
    
    
    
36. ELLIOTT JA, Klevebro F, Mantziari S, Markar SR, et al
    Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study.
    Ann Surg. 2023;278:692-700.
    PubMed     Abstract available
    
    
    
37. HWANG H, Choi JY, Yu HW, Moon JH, et al
    Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study.
    Ann Surg. 2023;278:e1087-e1095.
    PubMed     Abstract available
    
    
    June 2023
38. 
    Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study: Erratum.
    Ann Surg. 2023;277:e1397.
    PubMed    
    
    
    May 2023
39. BOERNER T, Harrington C, Tan KS, Adusumilli PS, et al
    Waiting to Operate: The Risk of Salvage Esophagectomy.
    Ann Surg. 2023;277:781-788.
    PubMed     Abstract available
    
    
    
40. YAN L, Liu Y, Li W, Zhu Y, et al
    Long-term Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study.
    Ann Surg. 2023;277:846-853.
    PubMed     Abstract available
    
    
    
41. BAYLEY EM, Ivy ML, Shewale JB, Ge PS, et al
    High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.
    Ann Surg. 2023;277:721-726.
    PubMed     Abstract available
    
    
    
42. 
    Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).
    Ann Surg. 2023;277:e1026-e1034.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum